Form 4 for ANIX Anixa Biosciences Inc
Accepted 2021-07-15 00:00:00 ET · period of report 2021-07-14 · accession 0001493152-21-016912 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-15 | 2021-07-14 | ANIX | Titterton Lewis H jr | Dir | P - Purchase | $3.72 | +23.3K | 893.6K | +3% | +$86.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-14 | P | A | 23,300 | $3.72 | 893,626 | D | — | — |